News

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a new supply agreement with the government of Colombia for 10.8 million doses…
Read More...

AiCuris Anti-infective Cures AG (AiCuris), a leading company in the discovery and development of drugs against infectious diseases, and Hybridize Therapeutics (Hybridize), focused on…
Read More...

Eli Lilly and Company announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least $720 million. The U.S. government…
Read More...

Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics…
Read More...

Active Biotech announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents relating to the use of tasquinimod…
Read More...

Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to…
Read More...

Verde Bio Holdings, Inc. with revenue producing mineral and royalty interests in more than 400 wells across the most active areas in the U.S., announced that it has acquired mineral and…
Read More...

Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule therapeutics across a broad range of…
Read More...

Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced the expansion of its Antibody-Drug Conjugate…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced an expanded partnership to supply more plasmid DNA (pDNA)…
Read More...

MaaT Pharma, a French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for patients…
Read More...

Sanofi announced the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine therapies. The acquisition also provides…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General (AG) of Texas that settles the…
Read More...

TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on its agreement with Elanco Animal Health Incorporated to acquire the…
Read More...

The life science group Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022,…
Read More...

Ovid Therapeutics a biopharmaceutical company committed to developing medicines that transform the lives of people with neurological diseases, and Healx, the AI-powered,…
Read More...

Azurity Pharmaceuticals, Inc., a private specialty pharmaceutical company, focused on developing innovative products to meet the unique needs of patients with underserved conditions,…
Read More...

Dyve Biosciences, Inc. announced a joint, two-year research collaboration with Moffitt Cancer Center. The collaboration will study Dyve’s systemic buffering agent, DYV800, utilizing its…
Read More...

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of…
Read More...

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that it has entered into a long-term lease agreement for a new…
Read More...